Sign inJoin waitlistJoin the waitlist

Arnab Basu

Physician · UAB Heersink School of Medicine

Credentials: · · · · · · · · · ·

History

UAB Heersink School of Medicine
2019–Present

Medical Oncology
2015–2017
Internal Medicine
Sinai Hospital of Baltimore
2012–2015
Calcutta National Medical College
2003–2007

Research

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Cancer · 2022 · 82 citations
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
The Lancet · 2024 · 75 citations
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
PLoS ONE · 2018 · 61 citations

Vadim Koshkin
11 papers · 1 as a fellow
Mehmet Bilen
10 papers
Deepak Kilari
8 papers
HE
Hamid Emamekhoo
8 papers
AJ
Albert Jang
7 papers · 7 as a resident
Amanda Nizam
7 papers · 7 as a fellow
Michael Glover
7 papers · 7 as a fellow
Petros Grivas
7 papers
Shilpa Gupta
7 papers
Sumit Shah
7 papers
AA
Ajjai Alva
6 papers
Ali Khaki
6 papers

Clinical trials

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2030
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2021–2033